Bavarian Nordic raises expectations after another EU monkeypox vaccine order
HERA, the EU’s health emergency preparedness agency, has doubled its order for the Danish drugmaker’s vaccine against monkeypox, and the company has subsequently upgraded its financial guidance for the seventh time this year.
by christian bundgaard, translated by daniel pedersen
A new order for an additional 170,000 doses of Bavarian Nordic’s monkeypox vaccine, sold as Imvanex in the EU, from the European Health Emergency Preparedness and Response Authority, HERA, is enough for the Danish drugmaker to raise its full-year expectations again, a company press release reports.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
